|
Market Closed -
Other stock markets
|
After hours 19:55:06 | |||
| 117.25 USD | +0.51% |
|
117.90 | +0.55% |
| 07-15 | BofA Securities Raises Incyte Price Target to $136 From $124 | MT |
| 07-14 | Barclays Adjusts Incyte Price Target to $134 From $117, Maintains Overweight Rating | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| INCYTE CORPORATION | Biopharmaceuticals | +0.51% | +0.46% | +18.71% | +70.08% | +49.69% | 23.42B |  | | |
- Stock Market
- Stocks
- INCY Stock
- Charts Incyte Corporation
- Comparison Chart
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
